The Short Version
A postbiotic is a preparation of inactivated (non-living) microbes and/or their components that still confers a health benefit. That is the official scientific definition, and the key word is inactivated: where a probiotic is live bacteria, a postbiotic is deliberately killed, usually by heat. Counterintuitive as that sounds, several trials show that some benefits do not require the bacteria to be alive.
Postbiotics are a real and credibly defined category, not pure marketing, and they carry genuine practical advantages: longer shelf stability, no refrigeration, and a better safety profile for people who should be cautious with live organisms. But "postbiotics work better than probiotics" is an overreach. The evidence base is far smaller, it is strain- and preparation-specific, and the two are better thought of as different tools than as an upgrade path. If a probiotic strain is helping you, there is no reason to switch.
Prebiotics, Probiotics, Postbiotics: Sorting the Terms
The "-biotics" family is easy to confuse, so here is the clean version:
- Probiotics are live microorganisms that, in adequate amounts, confer a health benefit. Think live Lactobacillus and Bifidobacterium strains. See our probiotics evidence review.
- Prebiotics are the fibers and compounds that feed your existing beneficial bacteria - inulin, fructooligosaccharides, and fibers like psyllium. They are food for microbes, not microbes themselves.
- Postbiotics are inactivated microbes and/or their components and metabolites. The bacteria are dead, but the structural parts and byproducts that produce benefits remain.
A useful shorthand: prebiotics are the food, probiotics are the live bacteria, and postbiotics are what is left when those bacteria have been intentionally inactivated but their functional parts are kept intact.
What Counts as a Postbiotic (the Official Definition)
The term was used loosely for years until a panel from the International Scientific Association of Probiotics and Prebiotics (ISAPP) published a 2021 consensus statement in Nature Reviews Gastroenterology and Hepatology (Salminen et al.) defining a postbiotic as a "preparation of inanimate microorganisms and/or their components that confers a health benefit on the host."
That definition does real work. It requires that the cells are deliberately inactivated, that the preparation is characterized, and that a health benefit is demonstrated. The panel also clarified what a postbiotic is not: purified individual metabolites like short-chain fatty acids on their own, vaccines, and filtrates with no cellular components fall outside the definition. This matters because product labels use "postbiotic" far more loosely than the science does, so the word on a bottle does not guarantee the product meets the consensus criteria.
Why Would Dead Bacteria Do Anything?
This is the question everyone asks, and the answer is that several of the mechanisms by which gut bacteria affect us do not actually depend on the cells being alive. The cell wall components, surface proteins, and metabolites produced before inactivation can still interact with the gut lining and immune system. Bacterial cell wall fragments can engage immune receptors; structural molecules can support the gut barrier; and metabolites carried in the preparation can have local effects. In other words, some of the "signal" a microbe sends is in its parts, not its pulse.
This is a mechanistic rationale, not a blanket guarantee. It explains why some specific inactivated preparations retain activity, while saying nothing about whether any given product on the shelf does.
Where the Evidence Is Actually Real
The strongest single piece of evidence comes from irritable bowel syndrome. A 2020 multicentre, randomized, double-blind, placebo-controlled trial in The Lancet Gastroenterology and Hepatology (Andresen et al.) tested a heat-inactivated strain of Bifidobacterium bifidum (MIMBb75) in IBS patients. The non-living preparation significantly reduced abdominal pain and overall IBS symptoms versus placebo over 8 weeks. The authors explicitly noted that the beneficial effects were mediated independently of cell viability - a direct demonstration that a postbiotic can work.
Beyond that landmark trial, the postbiotic evidence is genuinely early. There are smaller studies and reviews on inactivated preparations for immune support, infant digestive comfort, and some metabolic markers, but nothing approaching the breadth or replication that the better probiotic strains have accumulated over decades. The honest summary is: one strong proof-of-concept result, a scattering of promising smaller studies, and a lot of products that are ahead of their evidence.
The Practical Advantages Postbiotics Genuinely Have
Even with a thinner evidence base, postbiotics have real-world advantages that are not marketing spin:
- Shelf stability. Dead bacteria do not lose potency the way live cultures do. A major weakness of probiotics is that the CFU count on the label is at manufacture, and live counts decline with heat, time, and stomach acid. Inactivated preparations are far more stable, and many do not require refrigeration.
- Dose consistency. Because there is no die-off, the amount you take is closer to the amount that was tested.
- Safety profile. Live probiotics are generally safe for healthy people, but there are documented cautions for the seriously immunocompromised, critically ill, or those with central lines, where introducing live organisms carries rare but real risk. Inactivated preparations sidestep that specific concern. This is a context where a postbiotic may genuinely be preferable, and a clinician should be involved.
So, Does It Work "Better"?
This is the crux, and the honest answer is that "better" is the wrong frame. In our view, postbiotics are not a strict upgrade to probiotics; they are a different tool with a different evidence base.
- For breadth of proven uses, well-studied live probiotic strains still win, simply because they have decades of trials behind specific uses like antibiotic-associated diarrhea and certain IBS presentations.
- For stability and for caution around live organisms, postbiotics have a real edge.
- For most general "gut health" claims, neither category has strong evidence - that gap is the same for probiotics and postbiotics alike, as we cover in do probiotics actually work.
The marketing instinct to sell postbiotics as "probiotics 2.0" runs ahead of what has been shown. The biology is legitimate and the IBS trial is genuinely impressive, but one strong result does not generalize to every product that prints "postbiotic" on the label.
How to Evaluate a Postbiotic Product
The same discipline that separates good probiotics from hype applies here, with one twist:
- Named, characterized strain. Look for a specific inactivated strain with its own studies, the way the IBS evidence is tied to one defined B. bifidum preparation, not a generic "postbiotic blend." Strain specificity is everything; the lessons in our probiotic strains explained guide carry straight over.
- Dose that matches the studied amount, stated clearly rather than hidden in a proprietary blend.
- A defined benefit, not a vague "supports gut health." If the product cannot point to what was tested and at what dose, it is riding on the category's novelty.
For now, if you are choosing a gut-health product and want the deepest evidence base, a well-studied live strain remains the default - see our best probiotic supplement picks, the best probiotic for IBS ranking, and our broader supplements for gut health guide. Postbiotics are worth watching closely and worth choosing in the specific situations (stability needs, caution around live organisms) where their advantages are real. Compare specific live strains on our probiotic scorecard.
Sources
- Salminen S, Collado MC, Endo A, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021;18(9):649-667. PubMed
- Andresen V, Gschossmann J, Layer P. Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial. Lancet Gastroenterol Hepatol. 2020;5(7):658-666. PubMed
These statements have not been evaluated by the FDA. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. This article is educational and is not a substitute for individualized medical advice.